UTRECHT, Netherlands & GOTHENBURG, Sweden, September 14, 2026 / Biotech Newswire / -- Single Cell Discoveries (SCD), a specialist contract research organization (CRO) focused on discovery transcriptomics, has completed the acquisition of TATAA Biocenter, a globally recognized leader in qPCR, bioanalytical services, and molecular assay development. The combination creates one of Europe’s few specialist CROs able to take a molecular target from discovery to a validated, regulatory-ready result. Financial terms were not disclosed. Together, the two organizations employ approximately 50 scientists across Utrecht and Gothenburg, supporting pharmaceutical, biotechnology, and academic customers from discovery through validation and clinical development. SCD contributes single-cell sequencing, spatial transcriptomics, ...